When:  Sep 21, 2018 from 08:30 to 10:15 (CN)

Presented by the Chinese Society of Clinical Oncology (CSCO) in collaboration with the Chinese American Hematologist and Oncologist Network (CAHON) and the Society for Immunotherapy of Cancer (SITC).

The 8th CSCO-CAHON-SITC Joint Symposium in Immuno-oncology is part of the CSCO 21st Annual Meeting on September 19-23, 2018.

Symposium Agenda

Symposium Co-Chairs
  • Jin Li, MD, PhD
  • Wenru Song, MD, PhD
  • Lisa H. Butterfield, PhD, SITC President

Emerging Cancer Immunotherapy Modalities Above and Beyone Immune Checkpoint Blockers

8:30 a.m. – 8:50 a.m.

Novel Combination Immunotherapy of Non-small Cell Lung Cancer with PD-1 Blocker and IL-15 Superagonist
Mark P. Rubinstein, PhD* – Medical University of South Carolina, USA

8:50 a.m. – 9:10 a.m.

The Combination of Immunotherapy and Radiotherapy for Pancreatic Cancer: Who Invites Whom?
Lei Zheng, MD, PhD – Johns Hopkins University, USA

9:10 a.m. – 9:30 a.m.

CAR-T Therapy: Where Do We Go from Here?
Lisa H. Butterfield, PhD* – University of Pittsburgh, USA

9:30 a.m. – 9:50 a.m.

lo+Chemo vs. lo+Rt: Is There a Winner?
Bo Lu, MD – Thomas Jefferson University, USA

9:50 a.m. – 10:10 a.m.

Topic: TBD
Speaker: TBD

*Denotes SITC member.

For more information and to register, click here.


Xiamen International Conference Center
International Multifunctional Hall 3, 2nd Floor